@salomepinho.bsky.social
www.nature.com/articles/s41...
Mucosa glycans as key drivers of gut inflammation and #IBD
#glycotime @i3suporto.bsky.social
Mucosa glycans as key drivers of gut inflammation and #IBD
#glycotime @i3suporto.bsky.social
Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target - Nature Reviews Gastroenterology & Hepatology
Glycans are essential components of the gut mucosa that modulate epithelial barrier integrity, host–microbiota interactions and gut immune response. This Review discusses the role of mucosal glycans i...
www.nature.com
January 5, 2026 at 10:46 PM
www.nature.com/articles/s41...
Mucosa glycans as key drivers of gut inflammation and #IBD
#glycotime @i3suporto.bsky.social
Mucosa glycans as key drivers of gut inflammation and #IBD
#glycotime @i3suporto.bsky.social
An amazing week at University of Alberta 🇨🇦with plenty of #glycotime! A big thanks to @glycocode.bsky.social , @giaglyco.bsky.social and to @glyconet.bsky.social for the kind invitation!! Also great to see inspiring glyco-researchers that marked a generation
November 10, 2025 at 7:45 PM
An amazing week at University of Alberta 🇨🇦with plenty of #glycotime! A big thanks to @glycocode.bsky.social , @giaglyco.bsky.social and to @glyconet.bsky.social for the kind invitation!! Also great to see inspiring glyco-researchers that marked a generation
academic.oup.com/ecco-jcc/art...
Happy to share our most recent publication on how T cells glycosylation mediates #IBD progression to colorectal cancer defining the risk of colitis-associated cancer.
#glycotime Great work @eduardalgomes.bsky.social @i3suporto.bsky.social @GlycanTrigger
Happy to share our most recent publication on how T cells glycosylation mediates #IBD progression to colorectal cancer defining the risk of colitis-associated cancer.
#glycotime Great work @eduardalgomes.bsky.social @i3suporto.bsky.social @GlycanTrigger
T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease
AbstractBackground and Aims. Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract, established as a risk facto
academic.oup.com
April 30, 2025 at 5:06 PM
academic.oup.com/ecco-jcc/art...
Happy to share our most recent publication on how T cells glycosylation mediates #IBD progression to colorectal cancer defining the risk of colitis-associated cancer.
#glycotime Great work @eduardalgomes.bsky.social @i3suporto.bsky.social @GlycanTrigger
Happy to share our most recent publication on how T cells glycosylation mediates #IBD progression to colorectal cancer defining the risk of colitis-associated cancer.
#glycotime Great work @eduardalgomes.bsky.social @i3suporto.bsky.social @GlycanTrigger